<?xml version="1.0" encoding="UTF-8"?>
<urlset
  xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
  xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-hashimotos-thyroiditis-tpo-antibody-evidence</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 and Hashimoto&apos;s: TPO Antibodies, Weight Loss, and Levothyroxine</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-chronic-rhinosinusitis-nasal-polyps-evidence</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 in Chronic Rhinosinusitis and Nasal Polyps: Dupixent Stacking Evidence</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-interstitial-cystitis-bladder-pain-syndrome-evidence</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 in Interstitial Cystitis (IC/BPS): Diet, Elmiron, and Pelvic Floor Evidence</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-pelvic-floor-dysfunction-prolapse-incontinence-evidence</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 and Pelvic Floor: Stress Incontinence, Prolapse, and PT Evidence</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-chronic-urticaria-hives-xolair-evidence</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-30T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 in Chronic Urticaria: Xolair, Antihistamines, and Hives Evidence</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-birth-control-contraception-safety-evidence</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-29T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 + Birth Control: Tirzepatide Pill Warning + Wegovy / Ozempic</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/sesame-vs-lillydirect-zepbound-cash-pay-comparison</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-29T00:00:00.000Z</news:publication_date>
      <news:title>Sesame vs LillyDirect for Cash-Pay Zepbound: Which Is Cheapest?</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-and-metformin-stacking-weight-loss-evidence</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-29T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 + Metformin: Stacking for Weight Loss — The Real Math</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-naltrexone-alcohol-use-disorder-stacking-evidence</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-29T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 + Naltrexone for AUD: The Stacking Evidence</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/mounjaro-vs-zepbound-switching-evidence</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-29T00:00:00.000Z</news:publication_date>
      <news:title>Mounjaro vs Zepbound: Should You Switch? The Evidence</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-injection-timing-day-of-week-fasted-fed-evidence</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-29T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 Injection Timing: Day of Week, Time of Day, Fasted or Fed?</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/ozempic-face-filler-volume-restoration-evidence</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-29T00:00:00.000Z</news:publication_date>
      <news:title>Ozempic Face: When to Use Filler, Sculptra, or Surgery — Evidence</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/surmount-osa-zepbound-sleep-apnea-deep-dive</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-29T00:00:00.000Z</news:publication_date>
      <news:title>SURMOUNT-OSA: How Much Does Zepbound Improve Sleep Apnea?</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/retatrutide-triumph-phase-3-update-evidence</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-29T00:00:00.000Z</news:publication_date>
      <news:title>Retatrutide TRIUMPH Phase 3: Latest Pipeline Update</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-maintenance-de-escalation-step-down-protocol-evidence</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-29T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 Maintenance: Step-Down Dose Protocol — The Evidence</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-first-30-days-survival-guide-evidence</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-29T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 First 30 Days: Side Effect Survival Guide</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/amycretin-novo-pipeline-evidence</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-29T00:00:00.000Z</news:publication_date>
      <news:title>Amycretin: Novo&apos;s Next-Gen Dual Amylin/GLP-1 Drug</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-dpp4-sitagliptin-januvia-stacking-evidence</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-29T00:00:00.000Z</news:publication_date>
      <news:title>Januvia (Sitagliptin) Plus Ozempic: Should You Stack Them?</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-sglt2-jardiance-farxiga-stacking-evidence</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-29T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 + SGLT2 (Jardiance, Farxiga): The Stacking Evidence</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/trulicity-vs-ozempic-vs-mounjaro-t2d-evidence</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-29T00:00:00.000Z</news:publication_date>
      <news:title>Trulicity vs Ozempic vs Mounjaro for T2D: Head-to-Head Evidence</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-warfarin-eliquis-xarelto-anticoagulant-evidence</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-29T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 + Warfarin, Eliquis, or Xarelto: The Interaction Evidence</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-bariatric-surgery-bridge-decision-evidence</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-29T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 vs Bariatric Surgery: How to Decide in 2026</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/levothyroxine-synthroid-timing-glp1-absorption-evidence</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-29T00:00:00.000Z</news:publication_date>
      <news:title>Levothyroxine on Ozempic: Timing, Dose Changes, TSH Monitoring</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-endometriosis-pain-evidence</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-29T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 for Endometriosis: Pain, Inflammation, Weight Evidence</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-migraine-headache-cgrp-stacking-evidence</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-29T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 for Migraine: The Exenatide IIH Trial + Stacking Evidence</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/tirzepatide-vs-retatrutide-mechanism-comparison-evidence</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-29T00:00:00.000Z</news:publication_date>
      <news:title>Tirzepatide vs Retatrutide: GIP/GLP-1 vs Triple Agonist Evidence</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-ckd-flow-trial-kidney-function-evidence</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-29T00:00:00.000Z</news:publication_date>
      <news:title>FLOW Trial Update: GLP-1 for CKD Stage 3-4 — The Evidence</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-asthma-copd-lung-function-evidence</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-29T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 for Asthma and COPD: The Lung Function Evidence</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/wegovy-mash-essence-trial-fda-pathway-evidence</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-29T00:00:00.000Z</news:publication_date>
      <news:title>Wegovy for MASH: ESSENCE Trial Results + FDA Approval Pathway</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-step-hfpef-tirzepatide-summit-heart-failure-evidence</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-29T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 for HFpEF: STEP-HFpEF + SUMMIT Tirzepatide Trial Results</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-diabetic-retinopathy-ophthalmology-monitoring-evidence</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-29T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 + Diabetic Retinopathy: SUSTAIN-6 Signal + Monitoring</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-evoke-evoke-plus-alzheimers-prevention-evidence</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-29T00:00:00.000Z</news:publication_date>
      <news:title>EVOKE + EVOKE Plus: Semaglutide for Early Alzheimer&apos;s Disease</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-transplant-immunosuppressant-tacrolimus-evidence</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-29T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 in Transplant Patients: Tacrolimus, Sirolimus, Cellcept Safety</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-dialysis-esrd-stage-5-ckd-evidence</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-29T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 in Dialysis and Stage 5 CKD: What the Evidence Shows</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-breast-cancer-survivors-tamoxifen-letrozole-evidence</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-29T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 for Breast Cancer Survivors on Tamoxifen / Letrozole</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-history-of-pancreatitis-rechallenge-evidence</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-29T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 With History of Pancreatitis: Rechallenge Evidence</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-sickle-cell-disease-obesity-evidence</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-29T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 in Sickle Cell Disease: Safety + Obesity Considerations</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-sle-lupus-rheumatoid-arthritis-evidence</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-29T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 in Lupus and Rheumatoid Arthritis: Steroid Sparing Evidence</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-pcos-spironolactone-metformin-stacking-evidence</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-29T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 + Spironolactone + Metformin for PCOS: The Stacking Protocol</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-spinal-cord-injury-mobility-obesity-evidence</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-29T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 for Spinal Cord Injury Patients: Mobility-Limited Obesity</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-non-responder-phenotype-switching-strategy-evidence</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-29T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 Non-Responders: What to Do at 16 Weeks With &lt;5% Loss</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-gerd-ppi-omeprazole-stacking-evidence</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-29T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 + Omeprazole or Pantoprazole: GERD Management on Ozempic</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-hepatitis-c-cured-svr-metabolic-evidence</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-29T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 After Hepatitis C Cure (SVR): Metabolic Syndrome Reversal</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-cystic-fibrosis-modulator-era-obesity-evidence</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-29T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 in CF Modulator Era: New Obesity Considerations</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-hiv-art-integrase-inhibitor-weight-gain-evidence</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-29T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 for HIV Patients: ART-Related Weight Gain on Integrase Inhibitors</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-bipolar-lithium-mood-stabilizer-evidence</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-29T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 With Lithium, Lamictal, or Atypical Antipsychotics</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-parkinsons-disease-exenatide-lixisenatide-evidence</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-29T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 for Parkinson&apos;s Disease: Exenatide + Lixisenatide Trials</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-hypothalamic-obesity-craniopharyngioma-evidence</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-29T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 for Hypothalamic Obesity After Craniopharyngioma</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-osteoporosis-bone-density-bisphosphonate-evidence</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-29T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 + Osteoporosis: DEXA + Bisphosphonate Stacking Evidence</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-ibs-irritable-bowel-syndrome-evidence</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-29T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 in IBS-C and IBS-D: Symptom Management Evidence</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-epilepsy-keppra-lamictal-aed-evidence</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-29T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 With Keppra, Lamictal, and Other Antiseizure Medications</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-active-chemotherapy-cancer-treatment-evidence</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-29T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 During Active Chemotherapy: What the Evidence Shows</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-psoriasis-eczema-biologic-tnf-inhibitor-evidence</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-29T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 in Psoriasis and Eczema: TNF-Inhibitor and Dupixent Stacking</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-diuretics-furosemide-spironolactone-potassium-evidence</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-29T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 + Diuretics: Furosemide, HCTZ, Spironolactone Monitoring</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-acromegaly-cushings-pituitary-evidence</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-29T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 in Acromegaly and Cushing&apos;s: Pituitary Disease Considerations</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-allergic-rhinitis-immunotherapy-evidence</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-29T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 + Allergy Immunotherapy and Antihistamines</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-smoking-cessation-nicotine-varenicline-evidence</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-29T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 for Smoking Cessation: Chantix, Bupropion, and Nicotine Stacking</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-opioid-use-disorder-buprenorphine-methadone-evidence</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-29T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 for Opioid Use Disorder: Buprenorphine and Methadone Evidence</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-benzodiazepines-anxiety-stacking-evidence</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-29T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 + Benzodiazepines: Anxiety Management on Ozempic</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-binge-eating-disorder-bed-vyvanse-evidence</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-29T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 for Binge Eating Disorder: Vyvanse Comparison and Stacking Evidence</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-type-1-diabetes-t1d-insulin-pump-evidence</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-29T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 for Type 1 Diabetes: Off-Label Use With Insulin Pumps</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-perioperative-surgery-hold-asa-guidance-evidence</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-29T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 Before Surgery: When to Stop, ASA Anesthesia Guidance</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-dental-oral-health-periodontitis-evidence</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-29T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 and Dental Health: Periodontitis, Xerostomia, and Procedures</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-osteoarthritis-knee-step-9-evidence</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-29T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 for Knee Osteoarthritis: STEP-9 Evidence + Surgery Bridge</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-ptsd-prazosin-prolonged-exposure-evidence</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-29T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 With PTSD: Prazosin, Prolonged Exposure, Stellate Ganglion</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-vaccines-flu-covid-pneumococcal-evidence</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-29T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 and Vaccines: Flu, COVID, Pneumococcal Response Evidence</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-heart-rate-palpitations-tachycardia-evidence</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-29T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 and Heart Rate: Palpitations, Tachycardia, and Resting HR Evidence</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-gallstones-cholecystitis-gallbladder-evidence</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-29T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 and Gallstones: SUSTAIN-6 Signal + Cholecystectomy Risk Evidence</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-gout-uric-acid-allopurinol-evidence</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-29T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 and Gout: Uric Acid, Flares, and Allopurinol Stacking Evidence</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-iron-deficiency-anemia-ferritin-evidence</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-29T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 and Iron Deficiency: Ferritin, Anemia, Hair Loss Connection</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-fibromyalgia-chronic-pain-evidence</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-29T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 for Fibromyalgia and Chronic Pain: Anti-Inflammatory Evidence</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-tinnitus-hearing-otolaryngology-evidence</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-29T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 and Tinnitus: The FDA Reports + Postmarketing Evidence</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-endometrial-cancer-hyperplasia-prevention-evidence</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-29T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 and Endometrial Cancer: Obesity Reversal and Bleeding Workup</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-barretts-esophagus-surveillance-evidence</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-29T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 in Barrett&apos;s Esophagus: Weight Loss and Surveillance Evidence</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-hidradenitis-suppurativa-humira-cosentyx-evidence</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-29T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 for Hidradenitis Suppurativa: Weight Loss + Humira/Cosentyx Stacking</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-restless-legs-syndrome-iron-evidence</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-29T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 and Restless Legs Syndrome: Iron, Dopamine, and Mirapex Evidence</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-chronic-constipation-laxative-protocol-evidence</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-29T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 Constipation: The Step-by-Step Laxative Protocol That Actually Works</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-long-covid-post-acute-sequelae-evidence</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-29T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 for Long COVID: Inflammation, Fatigue, and Weight Recovery Evidence</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-glaucoma-intraocular-pressure-dry-eye-evidence</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-29T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 and Glaucoma: NAION Signal, IOP, and Dry Eye Evidence</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-acne-hormonal-spironolactone-evidence</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-29T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 and Acne: Insulin Resistance, Hormonal Acne, and Spironolactone</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-pots-dysautonomia-orthostatic-tachycardia-evidence</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-29T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 With POTS and Dysautonomia: Heart Rate, Salt, and Midodrine Evidence</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-atrial-fibrillation-afib-evidence</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-29T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 and Atrial Fibrillation: SELECT, FLOW, and Anticoagulation Stack</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-post-bariatric-hypoglycemia-acarbose-evidence</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-29T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 in Post-Bariatric Hypoglycemia: Acarbose, CGM, and PBH Protocol</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-kidney-stones-urolithiasis-prevention-evidence</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-29T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 and Kidney Stones: Urolithiasis Risk and Citrate Prevention Evidence</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-idiopathic-intracranial-hypertension-iih-exenatide-evidence</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-29T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 for IIH (Pseudotumor Cerebri): Mitchell Exenatide RCT + Weight Loss</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-recurrent-uti-cystitis-prevention-evidence</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-29T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 and Recurrent UTIs: Cranberry, Macrobid, and Hydration Evidence</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-sjogrens-syndrome-dry-eye-mouth-evidence</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-29T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 in Sjogren&apos;s Syndrome: Dry Eye, Dry Mouth, and HCQ Stacking</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-diabetic-foot-ulcer-wound-healing-evidence</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-29T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 for Diabetic Foot Ulcers: Wound Healing, Offloading, and Charcot Evidence</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-bph-tamsulosin-finasteride-urinary-evidence</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-29T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 and BPH: Tamsulosin, Finasteride, and Urinary Symptom Evidence</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.weightlossrankings.org/research/glp1-multiple-sclerosis-ms-dmt-evidence</loc>
    <news:news>
      <news:publication>
        <news:name>Weight Loss Rankings</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-29T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 in Multiple Sclerosis: DMT Stacking and Obesity Risk Evidence</news:title>
    </news:news>
  </url>
</urlset>